Institutional investors purchased a net $3.4 million shares of OPK during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 23.50% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 1.6 Million shares of OPKO Health Inc
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 1.6 Million shares of OPKO Health Inc
DEUTSCHE ASSET MANAGEMENT INVEST... Bought 1.0 Million shares of OPKO Health Inc